Tripty M Gandhi, MD
Family Practice · Santa Clara
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 8 carriers
- Office
- 1
Offices
1 location
Looking this up.
Plans that list them
31 plans · 8 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gandhi’s office at (408) 247-8100 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A60781 · Current
Licensed to practise in California · since 1996 · expires 2028-04-30 · University of Bombay, Seth G. S. Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
2023
Medicare did not publish checkup rates for this clinician.
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Original Medicare doctor bills
$3,939
Medicare paid this office $3,939 for 20 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 16 | $2,126 | $101 |
Who their Medicare patients are
20 Original Medicare patients in 2024. Average age 73 · Health risk score 1.01. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75%.
The office billed $8,175, Medicare allowed $6,249 and paid $3,939; for 38 services of 5 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 20 | 38 | 73 | 1.01 | $8,175 | $3,939 |
| 2023 | 21 | 31 | 74 | 0.98 | $6,860 | $3,306 |
| 2022 | 18 | 25 | 68 | 1.13 | $4,455 | $1,948 |
| 2021 | 81 | 96 | 65 | 1.23 | $10,370 | $5,667 |
| 2020 | 20 | 23 | 65 | 0.90 | $3,165 | $1,409 |
| 2019 | 13 | 30 | 75 | 1.05 | $5,660 | $2,444 |
| 2016 | 12 | 30 | 72 | 0.59 | $4,860 | $1,663 |
| 2014 | 12 | 37 | 74 | 0.66 | $5,920 | $2,352 |
| 2013 | 16 | 44 | 73 | 0.76 | $6,850 | $2,674 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2021: 4 services
| Return visit (30+ min) | 22 | $1,662 | $64 |
| New patient visit (45+ min) | 25 | $950 | $38 |
| Short return visit (20+ min) | 17 | $902 | $53 |
| New patient visit (30+ min) | 15 | $836 | $56 |
2019: 1 service
| Return visit (30+ min) | 11 | $1,603 | $84 |
2013: 1 service
| Return visit (30+ min) | 12 | $1,490 | $75 |
Medicaid work
$686 in 2024
Medicaid paid $686 for 209 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 83 | $541 |
| Return visit (30+ min) | 62 | $125 |
| New patient visit (45+ min) | 33 | $20 |
| New patient visit (60+ min) | 31 | $0 |
| 2024 | 209 | 4 | 22 | $686 |
| 2023 | 84 | 2 | 18 | $322 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 71 | $322 |
| New patient visit (60+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$29,764
Pharmacies billed $29,764 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 988) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
933 generic and fewer than 11 brand-name prescriptions · $29,764 in drug cost · 16 antibiotic prescriptions to 14 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 12 | $7,765 | $647 |
| Atorvastatin | 113 | $1,352 | $12 |
| Levothyroxine | 67 | $1,234 | $18 |
| Lisinopril | 79 | $851 | $11 |
| Rosuvastatin | 58 | $661 | $11 |
See all 20 drugs
| Trelegy Ellipta | 12 | $7,765 | $647 |
| Atorvastatin | 113 | $1,352 | $12 |
| Levothyroxine | 67 | $1,234 | $18 |
| Lisinopril | 79 | $851 | $11 |
| Rosuvastatin | 58 | $661 | $11 |
| Losartan | 43 | $632 | $15 |
| Metformin Hcl Er | 34 | $513 | $15 |
| Metformin | 51 | $496 | $10 |
| Metoprolol | 25 | $433 | $17 |
| Pantoprazole | 17 | $344 | $20 |
| Amlodipine Besylate | 71 | $341 | $5 |
| Hydrochlorothiazide | 40 | $192 | $5 |
| Simvastatin | 26 | $190 | $7 |
| Alendronate | 17 | $166 | $10 |
| Omeprazole | 17 | $147 | $9 |
| Tamsulosin | 16 | $133 | $8 |
| Allopurinol | 15 | $129 | $9 |
| Sertraline | 21 | $71 | $3 |
| Metoprolol | 15 | $69 | $5 |
| Trazodone | 13 | $52 | $4 |
Year by year
| 2024 | 988 | 114 | 0% (0) | None | $29,764 |
| 2023 | 704 | 91 | 0% (0) | None | $20,212 |
| 2022 | 554 | 65 | 0% (0) | None | $15,957 |
| 2021 | 436 | 101 | 0% (0) | 7% | $10,787 |
| 2020 | 333 | 48 | 0% (0) | 11% | $6,424 |
| 2019 | 319 | 45 | None | 13% | $7,604 |
| 2018 | 267 | 36 | None | None | $6,466 |
| 2017 | 371 | 34 | 0% (0) | None | $14,193 |
| 2016 | 406 | 42 | 0% (0) | None | $16,568 |
| 2015 | 441 | 33 | 0% (0) | 20% | $28,622 |
| 2014 | 501 | 37 | None | None | $27,449 |
| 2013 | 540 | 33 | None | None | $30,797 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Levothyroxine | 65 | $1,294 | $20 |
| Atorvastatin | 68 | $1,163 | $17 |
| Rosuvastatin | 36 | $942 | $26 |
| Lisinopril | 63 | $846 | $13 |
| Metformin | 37 | $666 | $18 |
| Amlodipine Besylate | 46 | $540 | $12 |
| Metoprolol | 18 | $500 | $28 |
| Losartan | 33 | $476 | $14 |
| Pantoprazole | 21 | $367 | $17 |
| Famotidine | 13 | $348 | $27 |
| Alendronate | 16 | $235 | $15 |
| Metformin Hcl Er | 13 | $184 | $14 |
| Hydrochlorothiazide | 25 | $181 | $7 |
| Simvastatin | 16 | $177 | $11 |
| Tamsulosin | 13 | $158 | $12 |
2022: 13 drugs
| Levothyroxine | 59 | $1,237 | $21 |
| Atorvastatin | 59 | $828 | $14 |
| Rosuvastatin | 16 | $581 | $36 |
| Lisinopril | 41 | $297 | $7 |
| Metformin | 40 | $293 | $7 |
| Alendronate | 18 | $227 | $13 |
| Amlodipine Besylate | 29 | $189 | $7 |
| Pantoprazole | 13 | $177 | $14 |
| Metoprolol | 12 | $171 | $14 |
| Paroxetine | 13 | $163 | $13 |
| Simvastatin | 16 | $162 | $10 |
| Losartan | 24 | $147 | $6 |
| Hydrochlorothiazide | 15 | $56 | $4 |
2021: 12 drugs
| Levothyroxine | 35 | $672 | $19 |
| Atorvastatin | 35 | $447 | $13 |
| Lisinopril | 40 | $329 | $8 |
| Losartan | 16 | $242 | $15 |
| Metformin Hcl Er | 11 | $238 | $22 |
| Nitrofurantoin Mono-Macro | 15 | $212 | $14 |
| Alendronate | 21 | $189 | $9 |
| Simvastatin | 13 | $128 | $10 |
| Furosemide | 13 | $119 | $9 |
| Amoxicillin-Clavulanate Potass | 12 | $106 | $9 |
| Hydrochlorothiazide | 21 | $104 | $5 |
| Amlodipine Besylate | 13 | $71 | $5 |
2020: 9 drugs
| Levothyroxine | 41 | $904 | $22 |
| Atorvastatin | 25 | $397 | $16 |
| Alendronate | 26 | $323 | $12 |
| Lisinopril | 30 | $279 | $9 |
| Losartan | 13 | $224 | $17 |
| Amlodipine Besylate | 16 | $168 | $10 |
| Simvastatin | 18 | $135 | $8 |
| Omeprazole | 11 | $132 | $12 |
| Furosemide | 12 | $46 | $4 |
2019: 6 drugs
| Levothyroxine | 47 | $952 | $20 |
| Atorvastatin | 34 | $658 | $19 |
| Lisinopril | 31 | $412 | $13 |
| Amlodipine Besylate | 18 | $210 | $12 |
| Alendronate | 12 | $138 | $11 |
| Simvastatin | 17 | $128 | $8 |
2018: 8 drugs
| Levothyroxine | 24 | $589 | $25 |
| Atorvastatin | 15 | $390 | $26 |
| Lisinopril | 22 | $296 | $13 |
| Omeprazole | 11 | $238 | $22 |
| Simvastatin | 21 | $216 | $10 |
| Amlodipine Besylate | 14 | $187 | $13 |
| Alendronate | 11 | $137 | $12 |
| Metformin | 18 | $125 | $7 |
2017: 8 drugs
| Levothyroxine | 29 | $682 | $24 |
| Simvastatin | 42 | $422 | $10 |
| Lisinopril | 28 | $214 | $8 |
| Omeprazole | 21 | $210 | $10 |
| Amlodipine Besylate | 25 | $192 | $8 |
| Atorvastatin | 13 | $166 | $13 |
| Metformin | 26 | $108 | $4 |
| Carvedilol | 17 | $101 | $6 |
2016: 9 drugs
| Levothyroxine | 35 | $617 | $18 |
| Simvastatin | 34 | $322 | $9 |
| Lisinopril | 38 | $290 | $8 |
| Amlodipine Besylate | 36 | $237 | $7 |
| Atorvastatin | 14 | $234 | $17 |
| Carvedilol | 23 | $231 | $10 |
| Omeprazole | 11 | $146 | $13 |
| Metformin | 19 | $144 | $8 |
| Furosemide | 14 | $105 | $8 |
2015: 12 drugs
| Pristiq Er | 11 | $2,816 | $256 |
| Proair Hfa | 11 | $1,370 | $125 |
| Levothyroxine | 19 | $530 | $28 |
| Atorvastatin | 22 | $519 | $24 |
| Lisinopril | 52 | $464 | $9 |
| Simvastatin | 27 | $418 | $15 |
| Tamsulosin | 13 | $321 | $25 |
| Amlodipine Besylate | 36 | $270 | $7 |
| Metformin | 21 | $216 | $10 |
| Carvedilol | 15 | $189 | $13 |
| Omeprazole | 11 | $170 | $15 |
| Paroxetine | 15 | $135 | $9 |
2014: 15 drugs
| Flovent Hfa | 12 | $3,466 | $289 |
| Proair Hfa | 12 | $1,460 | $122 |
| Simvastatin | 34 | $706 | $21 |
| Atorvastatin | 25 | $600 | $24 |
| Lisinopril | 53 | $479 | $9 |
| Levothyroxine | 22 | $456 | $21 |
| Omeprazole | 12 | $438 | $37 |
| Carvedilol | 17 | $281 | $17 |
| Amlodipine Besylate | 29 | $278 | $10 |
| Tamsulosin | 17 | $248 | $15 |
| Metformin | 33 | $226 | $7 |
| Alendronate | 14 | $152 | $11 |
| Hydrochlorothiazide | 16 | $114 | $7 |
| Glipizide | 11 | $91 | $8 |
| Atenolol | 11 | $74 | $7 |
2013: 16 drugs
| Flovent Hfa | 13 | $3,006 | $231 |
| Fenofibrate | 15 | $2,060 | $137 |
| Atorvastatin | 26 | $1,390 | $53 |
| Proair Hfa | 11 | $1,240 | $113 |
| Simvastatin | 51 | $539 | $11 |
| Lisinopril | 46 | $461 | $10 |
| Carvedilol | 27 | $429 | $16 |
| Clopidogrel | 14 | $355 | $25 |
| Levothyroxine | 21 | $351 | $17 |
| Amlodipine Besylate | 34 | $317 | $9 |
| Omeprazole | 11 | $264 | $24 |
| Metformin | 34 | $232 | $7 |
| Losartan-Hydrochlorothiazide | 11 | $230 | $21 |
| Paroxetine | 12 | $109 | $9 |
| Azithromycin | 11 | $106 | $10 |
| Atenolol | 13 | $66 | $5 |
Money from drug and device companies
$475 in 2025
| 2025 | 4 | 4 | None | $475 |
| 2024 | 3 | 3 | None | $362 |
| 2023 | 2 | 4 | None | $465 |
| 2022 | 3 | 3 | None | $232 |
| 2021 | 2 | 2 | None | $148 |
| 2020 | 1 | 1 | None | $125 |
| 2019 | 6 | 7 | None | $859 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| InSightec | Exablate | $143 | 1 payment
|
| Dompe US | Oxervate | $125 | 1 payment
|
| Mayne Pharma Commercial | Bijuva | $122 | 1 payment
|
| Abbott Laboratories | Freestyle Libre 3 | $85 | 1 payment
|
See all 4 published payments
| Abbott Laboratories | Meals · 2025-10-02 | Freestyle Libre 3 | $85 |
| InSightec | Meals · 2025-08-26 | Exablate | $143 |
| Mayne Pharma Commercial | Meals · 2025-08-20 | Bijuva | $122 |
| Dompe US | Meals · 2025-07-17 | Oxervate | $125 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $362
| Amgen | Tepezza | $125 | 1 payment
|
| Dompe US | Oxervate | $125 | 1 payment
|
| Si-Bone | None | $112 | 1 payment
|
2023: $465
| Mayne Pharma Commercial | Nextstellis | $247 | 2 payments
|
| Medtronic | Kyphon Express II Kyphopak Tray | $218 | 2 payments
|
2022: $232
| Sun Pharmaceutical Industries | Cequa | $195 | 1 payment
|
| Abbvie | Qulipta | $19 | 1 payment
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $18 | 1 payment
|
2021: $148
| Allergan | None | $125 | 1 payment
|
| Novo Nordisk | Ozempic | $23 | 1 payment
|
2020: $125
| Allergan | None | $125 | 1 payment
|
2019: $859
| Teva Pharmaceuticals USA | Ajovy | $250 | 2 payments
|
| Genentech USA | Lucentis | $125 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $125 | 1 payment
|
| Radius Health | Tymlos | $125 | 1 payment
|
| AbbVie | Humira | $125 | 1 payment
|
| Boston Scientific | General Therapies | $110 | 1 payment
|
Professional record
- NPI
- 1700829512
- Licence
- CA A60781California A60781: Current · expires 2028-04-30
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1080 Scott Blvd, Suite 5, Santa Clara, CA, 95050
- NPI first listed
- 2006-06-13
- NPI last updated
- 2009-12-11
This is when the NPI record was last certified, not a medical board exam.